Add-on Acquisition • Life Science

Lupin Acquires Laboratorios Grin S.A. de C.V.

On September 30, 2014, Lupin acquired life science company Laboratorios Grin S.A. de C.V.

Acquisition Context
  • This is Lupin’s 3rd transaction in the Life Science sector.
  • This is Lupin’s 1st transaction in Mexico.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date September 30, 2014
Target Laboratorios Grin S.A. de C.V.
Sector Life Science
Buyer(s) Lupin
Deal Type Add-on Acquisition

Target Company

Laboratorios Grin S.A. de C.V.

Mexico City, Mexico
Laboratorios Grin S.A. de C.V. is a specialty pharmaceutical company engaged in the development, manufacturing & commercialization of branded Ophthalmic products.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Lupin

Mumbai, India

Category Company
Founded 1968
Sector Life Science
Employees24,006
Revenue 221.9B INR (2025)
DESCRIPTION

Lupin is an innovation-led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products. Lupin was founded in 1968 and is based in Mumbai, Maharashtra.


Deal Context for Buyer #
Overall 3 of 11
Sector: Life Science 3 of 9
Type: Add-on Acquisition 2 of 7
Country: Mexico 1 of 1
Year: 2014 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-30 Nanomi B.V.

Oldenzaal, Netherlands

Nanomi B.V. is a drug delivery company that develops pharmaceutical products based on nano- and microparticles. Nanomi targets business-to-business partnerships with pharma and biotech companies.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-02 Biocom ZAO

Russia

Biocom ZAO is a pharmaceutical company.

Buy -